Shares of Citius Pharmaceuticals (NASDAQ: CTXR) have shot about 270% higher this year. That's an amazing run for a biotech stock that most of us hadn't even heard of yet.
Now that the stock has produced some eye-popping gains, investors of all stripes want to know if it can deliver more. Let's look at the road ahead of this drug maker to see if it can keep performing for your portfolio or if investors following its big run-up are headed for trouble.
Image source: Getty Images.
For further details see:
Is It Too Late to Buy Citius Pharmaceuticals Stock?